<?xml version='1.0' encoding='UTF-8'?><rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/" xmlns:blogger="http://schemas.google.com/blogger/2008" xmlns:georss="http://www.georss.org/georss" xmlns:gd="http://schemas.google.com/g/2005" xmlns:thr="http://purl.org/syndication/thread/1.0" version="2.0"><channel><atom:id>tag:blogger.com,1999:blog-6400708663401817028</atom:id><lastBuildDate>Fri, 14 Sep 2018 14:04:06 +0000</lastBuildDate><category>FDA</category><category>AeroShot</category><category>domodrugs</category><category>domopharma</category><category>ADHD</category><category>Adderall</category><category>Bing for Pharma</category><category>Blepharospasm</category><category>Botox</category><category>Botox Cosmetic</category><category>Cervical dystonia</category><category>Drug Recalls</category><category>Drug Regulation</category><category>Dysport</category><category>FDA Alert</category><category>FDA Warning</category><category>Google for drugs</category><category>Hospira</category><category>Lucinactant</category><category>MILLIPRED</category><category>MicroCHIPS</category><category>Myobloc</category><category>NDC0555-0768-02</category><category>OTC</category><category>OncoWikia</category><category>Overactive Bladder</category><category>Pill millipedes</category><category>Prescription for Danger</category><category>Remote controlled drug delivery.</category><category>Reumofan Plus</category><category>Rx</category><category>Strabismus</category><category>Surfaxin</category><category>Teva</category><category>Yahoo for Medicine</category><category>amphetamine aspartate</category><category>botulinum</category><category>caffeine inhaler</category><category>depressants</category><category>dextroamphetamine sulfate</category><category>drug abuse</category><category>drug search</category><category>extroamphetamine saccharate</category><category>painkillers</category><category>teriparatide</category><title>Domo Pharma</title><description>We will bring focus to Pharma. Semantic Drug Search Engine.</description><link>http://domopharma.blogspot.com/</link><managingEditor>noreply@blogger.com (ravenII)</managingEditor><generator>Blogger</generator><openSearch:totalResults>10</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><item><guid isPermaLink="false">tag:blogger.com,1999:blog-6400708663401817028.post-1685468344493987812</guid><pubDate>Tue, 22 Jan 2013 15:16:00 +0000</pubDate><atom:updated>2013-01-22T07:16:29.482-08:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Blepharospasm</category><category domain="http://www.blogger.com/atom/ns#">Botox</category><category domain="http://www.blogger.com/atom/ns#">Botox Cosmetic</category><category domain="http://www.blogger.com/atom/ns#">botulinum</category><category domain="http://www.blogger.com/atom/ns#">Cervical dystonia</category><category domain="http://www.blogger.com/atom/ns#">Dysport</category><category domain="http://www.blogger.com/atom/ns#">Myobloc</category><category domain="http://www.blogger.com/atom/ns#">Overactive Bladder</category><category domain="http://www.blogger.com/atom/ns#">Strabismus</category><title>What Is Botox, (Botulinum Toxin Type A)?</title><description>&lt;br /&gt;Botox (botulinum toxin type A)&amp;nbsp;is a synthetic form of toxin or the biological toxin produced by the bacterium Clostridium botulinum. It&#39;s the same toxin that causes a life-threatening type of food poisoning called botulism. If one consumes the toxin, orally, in sufficiant ammounts, the toxin blocks nerve signals from a persons brin to the muscles, paralyzing the person. Immediate medical care must be&amp;nbsp;sought&amp;nbsp;if botulism poisoning is suspected.&lt;br /&gt;&lt;br /&gt;Alan Scott, MD, a San Francisco ophthalmologist, and Edward Schantz were the first to work on a standardized botulinum toxin preparation for therapeutic purposes. The same toxin, in very small amounts are used by doctors to treat health and cosmetic problems, including;&lt;br /&gt;&lt;br /&gt;Temporary removal of facial wrinkles&lt;br /&gt;Severe underarm sweating&lt;br /&gt;&lt;b&gt;Cervical dystonia&lt;/b&gt; - a neurological disorder that causes severe neck and shoulder muscle contractions&lt;br /&gt;&lt;b&gt;Blepharospasm&lt;/b&gt; - uncontrollable blinking&lt;br /&gt;&lt;b&gt;Strabismus&lt;/b&gt; - misaligned eyes or lazy eyes&lt;br /&gt;&lt;a href=&quot;http://meddesktop.blogspot.com/2013/01/botox-approved-to-treat-overactive.html&quot; target=&quot;_blank&quot;&gt;&lt;b&gt;Overactive Bladder&lt;/b&gt; Treatment&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;There are more than 119 clinical research involved in treating various other conditions with Botox.&lt;br /&gt;Botox injections work by weakening or paralyzing certain muscles or by blocking certain nerves. The effects last about three to four months. Side effects can include pain at the injection site, flu-like symptoms, headache and upset stomach. Injections in the face may also cause temporary drooping eyelids. You should not use Botox if you are pregnant or breast feeding.&lt;br /&gt;&lt;br /&gt;According to FDA, there are three botulinum toxin product in this class,&lt;br /&gt;OnabotulinumtoxinA (marketed as &lt;b&gt;Botox/Botox Cosmetic&lt;/b&gt;),&lt;br /&gt;AbobotulinumtoxinA (marketed as &lt;b&gt;Dysport&lt;/b&gt;)&lt;br /&gt;and&lt;br /&gt;RimabotulinumtoxinB (marketed as &lt;b&gt;Myobloc&lt;/b&gt;)&lt;br /&gt;&lt;br /&gt;Information for Healthcare Professionals by &lt;a href=&quot;http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm174949.htm&quot; target=&quot;_blank&quot;&gt;FDA&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;For more &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed?term=botulinum+toxin+type+a/tu[mh]+AND+humans[mh]+AND+english[la]+AND+(review[pt]+OR+guideline[pt]+OR+clinical+trial[pt]+OR+jsubsetk[text]+OR+jsubsetaim[text]+OR+jsubsetn[text]+OR+patient+education+handout[pt])+NOT+(letter[pt]+OR+editorial[pt]+OR+case+reports[pt])+AND+%22last+1+Year%22[edat]&quot; target=&quot;_blank&quot;&gt;Journal Articles&lt;/a&gt;.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style=&quot;font-size: x-small;&quot;&gt;MYOBLOC® is a registered trademark of Solstice Neurosciences, Inc.&lt;/span&gt;&lt;br /&gt;&lt;span style=&quot;font-size: x-small;&quot;&gt;Botox® marks owned by Allergan, Inc.&lt;/span&gt;&lt;br /&gt;&lt;span style=&quot;font-size: x-small;&quot;&gt;Dysport™ is manufactured by Ipsen Biopharm Ltd.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;</description><link>http://domopharma.blogspot.com/2013/01/what-is-botox-botulinum-toxin-type-a.html</link><author>noreply@blogger.com (Diordna)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-6400708663401817028.post-1584897311207334751</guid><pubDate>Wed, 06 Jun 2012 16:44:00 +0000</pubDate><atom:updated>2012-06-06T09:44:02.988-07:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Adderall</category><category domain="http://www.blogger.com/atom/ns#">AeroShot</category><category domain="http://www.blogger.com/atom/ns#">amphetamine aspartate</category><category domain="http://www.blogger.com/atom/ns#">dextroamphetamine sulfate</category><category domain="http://www.blogger.com/atom/ns#">extroamphetamine saccharate</category><category domain="http://www.blogger.com/atom/ns#">FDA</category><category domain="http://www.blogger.com/atom/ns#">FDA Warning</category><category domain="http://www.blogger.com/atom/ns#">NDC0555-0768-02</category><category domain="http://www.blogger.com/atom/ns#">Teva</category><title>Counterfeit Of Teva’s Adderall In Circulation, FDA Warns.</title><description>FDA is warning public of a counterfeit version of Teva&#39;s Adderall (an Approved drug), used to treat attention deficit hyperactivity disorders (ADHD) and  narcolepsy. The Adderall &amp;nbsp; is classified as a controlled substance, a  class of drugs for which special controls are required for distribution.&lt;br /&gt;FDA found wrong active ingredients, completely different from the authentic Adderall..Counterfeiters are using the current shortage of the Adderall to distribute counterfeit drugs over the internet.&lt;br /&gt;If your Adderall matches the following description, please stop using them and consult your physician, as the counterfeit versions of Adderall should be  considered as unsafe, ineffective and potentially harmful. &lt;br /&gt;According to FDA;&lt;br /&gt;&lt;blockquote class=&quot;tr_bq&quot;&gt;&lt;b&gt;The Adderall 30 mg product may be counterfeit if:&lt;/b&gt;&lt;br /&gt;&lt;b&gt;1. The product comes in a blister package.&lt;/b&gt;&lt;br /&gt;&lt;b&gt;2. There are misspellings on the package.&lt;/b&gt;&lt;br /&gt;&lt;ul&gt;&lt;li&gt;&lt;b&gt;“NDS” instead of “NDC” &lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;“Aspartrte” instead of “Aspartate” &lt;/b&gt;&lt;/li&gt;&lt;li&gt;&lt;b&gt;“Singel” instead of “Single”&lt;/b&gt;&lt;/li&gt;&lt;/ul&gt;&lt;b&gt;3. The tablets are white in color, round in shape, and are smooth.&lt;/b&gt;&lt;br /&gt;&lt;b&gt;4. The tablets have no markings on them&lt;/b&gt;&lt;/blockquote&gt;&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;&lt;a href=&quot;http://3.bp.blogspot.com/-mGgj6Txf2P8/T8-HEpbq8rI/AAAAAAAAG84/-xYm-nteUxo/s1600/counterfeit+Adderall.jpg&quot; imageanchor=&quot;1&quot; style=&quot;margin-left: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;130&quot; src=&quot;http://3.bp.blogspot.com/-mGgj6Txf2P8/T8-HEpbq8rI/AAAAAAAAG84/-xYm-nteUxo/s400/counterfeit+Adderall.jpg&quot; width=&quot;400&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;&lt;a href=&quot;http://3.bp.blogspot.com/-lTC5MczeIvo/T8-HGeiQ_vI/AAAAAAAAG9A/WYOP2-Y3Mbc/s1600/counterfeit+Adderall+2.jpg&quot; imageanchor=&quot;1&quot; style=&quot;margin-left: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;191&quot; src=&quot;http://3.bp.blogspot.com/-lTC5MczeIvo/T8-HGeiQ_vI/AAAAAAAAG9A/WYOP2-Y3Mbc/s400/counterfeit+Adderall+2.jpg&quot; width=&quot;400&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;The authentic Teva&#39;s Adderall 30 mg tablets produced by Teva are round, orange/peach,  and scored tablets with “dp” embossed on one side and “30” on the other side of  the tablet. Teva’s Adderall 30 mg tablets are packaged only in a 100-count  bottle with the National Drug Code (NDC) 0555-0768-02 listed&lt;br /&gt;&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;&lt;a href=&quot;http://2.bp.blogspot.com/-L5pVtIHyo5Q/T8-HrrZQGOI/AAAAAAAAG9I/ZR3ECz2vUxI/s1600/authentic+Adderall.jpg&quot; imageanchor=&quot;1&quot; style=&quot;margin-left: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;193&quot; src=&quot;http://2.bp.blogspot.com/-L5pVtIHyo5Q/T8-HrrZQGOI/AAAAAAAAG9I/ZR3ECz2vUxI/s400/authentic+Adderall.jpg&quot; width=&quot;400&quot; /&gt;&lt;/a&gt;&lt;/div&gt;&lt;br /&gt;Press Release by FDA;&lt;br /&gt;&lt;br /&gt;&lt;blockquote class=&quot;tr_bq&quot;&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;For Immediate Release: May 29, 2012&lt;br /&gt;Media  Inquiries: Shelly Burgess, 301-796-4651, &lt;a href=&quot;mailto:shelly.burgess@fda.hhs.gov&quot;&gt;shelly.burgess@fda.hhs.gov&lt;/a&gt;  &lt;br /&gt;Consumer Inquiries: 888-INFO-FDA&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;FDA warns consumers about counterfeit version of Teva’s  Adderall&lt;/strong&gt;&lt;em&gt;Tablets purchased on the Internet contain wrong active  ingredients&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;The U.S. Food and Drug Administration is warning consumers and health care  professionals about a counterfeit version of Teva Pharmaceutical Industries’  Adderall 30 milligram tablets that is being purchased on the Internet. Adderall,  which is approved to treat attention deficit hyperactivity disorders (ADHD) and  narcolepsy, is a prescription drug classified as a controlled substance – a  class of drugs for which special controls are required for dispensing by  pharmacists.&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;FDA’s preliminary laboratory tests revealed that the counterfeit version of  Teva’s Adderall 30 mg tablets contained the wrong active ingredients. Adderall  contains four active ingredients – dextroamphetamine saccharate, amphetamine  aspartate, dextroamphetamine sulfate, and amphetamine sulfate. Instead of these  active ingredients, the counterfeit product contained tramadol and  acetaminophen, which are ingredients in medicines used to treat acute pain.&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;Currently on the FDA’s drug shortage list, Adderall is in short supply due to  active pharmaceutical ingredient supply issues. Teva continues to release  product as it becomes available. Consumers should be extra cautious when buying  their medicines from online sources.  Rogue websites and distributors may  especially target medicines in short supply for counterfeiting.&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;The counterfeit Adderall tablets are round, white and do not have any type of  markings, such as letters or numbers. Any product that resembles the tablets or  the packaging in the photos below and claims to be Teva’s Adderall 30 mg tablets  should be considered counterfeit. The counterfeit versions of Adderall should be  considered as unsafe, ineffective and potentially harmful.&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;Authentic Adderall 30 mg tablets produced by Teva are round, orange/peach,  and scored tablets with “dp” embossed on one side and “30” on the other side of  the tablet. Teva’s Adderall 30 mg tablets are packaged only in a 100-count  bottle with the National Drug Code (NDC) 0555-0768-02 listed&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;The Adderall 30 mg product may be counterfeit if:&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;1. The product comes in a blister package.&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;2. There are misspellings on the package.&lt;/div&gt;&lt;ul style=&quot;text-align: justify;&quot;&gt;&lt;li&gt;“NDS” instead of “NDC” &lt;/li&gt;&lt;li&gt;“Aspartrte” instead of “Aspartate” &lt;/li&gt;&lt;li&gt;“Singel” instead of “Single”&lt;/li&gt;&lt;/ul&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;3. The tablets are white in color, round in shape, and are smooth.&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;4. The tablets have no markings on them&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;Anyone who believes they have the counterfeit version of Teva’s Adderall 30  mg tablets should not take or should stop taking the product. Consumers should  talk to their health care professional about their condition and options for  treatment.&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;Consumers and health care professionals are encouraged to report adverse  events or side effects from the suspect counterfeit Adderall to the FDA’s  MedWatch Safety Information and Adverse Event Reporting Program:&lt;/div&gt;&lt;ul style=&quot;text-align: justify;&quot;&gt;&lt;li&gt;Complete and submit the report online: &lt;a href=&quot;http://www.fda.gov/MedWatch/report.htm&quot;&gt;www.fda.gov/MedWatch/report.htm&lt;/a&gt;&lt;span class=&quot;footnote_number&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;. &lt;/li&gt;&lt;li&gt;&lt;a href=&quot;https://www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm&quot; target=&quot;_blank&quot;&gt;Download form&lt;/a&gt;&lt;span class=&quot;footnote_number&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt;  or call 1-800-332-1088 to request a reporting form, then complete and return to  the address on the pre-addressed form, or submit by fax to  1-800-FDA-0178. &lt;/li&gt;&lt;/ul&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;Consumers who believe they have received counterfeit  Adderall should contact the FDA’s Office of Criminal Investigations (OCI) at  800-551-3989 or &lt;a href=&quot;http://www.fda.gov/OCI&quot;&gt;http://www.fda.gov/OCI&lt;/a&gt;&lt;span class=&quot;footnote_number&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;&lt;/span&gt;.&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;For more information:&lt;/div&gt;&lt;ul style=&quot;text-align: justify;&quot;&gt;&lt;li&gt;&lt;a href=&quot;http://www.blogger.com/ForConsumers/ProtectYourself/default.htm&quot; target=&quot;&quot;&gt;Buying Medicines and Medical Products Online&lt;/a&gt;&lt;span class=&quot;footnote_number&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;The FDA, an agency within the U.S. Department of Health and Human Services,  protects the public health by assuring the safety, effectiveness, and security  of human and veterinary drugs, vaccines and other biological products for human  use, and medical devices. The agency also is responsible for the safety and  security of our nation’s food supply, cosmetics, dietary supplements, products  that give off electronic radiation, and for regulating tobacco products.&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;/blockquote&gt;</description><link>http://domopharma.blogspot.com/2012/06/counterfeit-of-tevas-adderall-in.html</link><author>noreply@blogger.com (ravenII)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://3.bp.blogspot.com/-mGgj6Txf2P8/T8-HEpbq8rI/AAAAAAAAG84/-xYm-nteUxo/s72-c/counterfeit+Adderall.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-6400708663401817028.post-294563490946396782</guid><pubDate>Wed, 06 Jun 2012 16:14:00 +0000</pubDate><atom:updated>2012-06-06T09:14:28.994-07:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">FDA Alert</category><category domain="http://www.blogger.com/atom/ns#">Reumofan Plus</category><title>FDA Issues An Alert On Reumofan Plus</title><description>Food and Drug Administration is alerting people on &lt;b&gt;Reumofan  Plus&lt;/b&gt; marketed as a Natural dietary supplement for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions..&lt;br /&gt;Consumers who are currently taking Reumofan Plus or who have recently stopped  taking Reumofan Plus should immediately consult a health care professional.  Consumers should not buy or start using the product. &lt;br /&gt;Follow the link for the pictures of Reumofan Plus and the full FDA press release, both in English and En Español.&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://meddesktop.blogspot.com/2012/06/reumofan-plus-alert-by-fda-health.html&quot;&gt;Reumofan Plus Alert By FDA | Health Officials In Mexico Recall The Dietary Supplement&lt;/a&gt;</description><link>http://domopharma.blogspot.com/2012/06/fda-issues-alert-on-reumofan-plus.html</link><author>noreply@blogger.com (ravenII)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-6400708663401817028.post-2911304277373803609</guid><pubDate>Mon, 14 May 2012 22:11:00 +0000</pubDate><atom:updated>2012-05-14T15:11:32.796-07:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Drug Recalls</category><category domain="http://www.blogger.com/atom/ns#">Hospira</category><title>Hospira Recalls Hydromorphone HCI</title><description>Recallr has information on Hospira&amp;nbsp;Hospira Recalls Hydromorphone HCI recall.&lt;br /&gt;&lt;span style=&quot;background-color: white; font-family: &#39;Trebuchet MS&#39;, Trebuchet, Verdana, sans-serif; font-size: 14px;&quot;&gt;Anyone with an existing inventory of&amp;nbsp;&lt;/span&gt;Hydromorphone Hydrochloride Injection 1 MG/ML, (C-II) 1 ML Fill In 2.5 ML Carpuject&amp;nbsp;&lt;span style=&quot;background-color: white; font-family: &#39;Trebuchet MS&#39;, Trebuchet, Verdana, sans-serif; font-size: 14px;&quot;&gt;should stop use and distribution, quarantine the product immediately, and call Stericycle at 1-888-912-7093 to arrange for the return of the product. Replacement product from other lots is available. Customers can send their DEA 222 form to Hospira, 1635 Stone Ridge Drive, Stone Mountain, GA 30083 to order replacement product. For medical inquiries, please contact Hospira Medical Communications at 1-800-615-0187. This phone number is available 24 hours a day, seven days a week.&lt;/span&gt;&lt;br /&gt;&lt;a href=&quot;http://recallsglobal.blogspot.com/2012/05/hospira-recalls-hydromorphone.html&quot;&gt;Recallr: Hospira Recalls Hydromorphone Hydrochloride Injection 1 MG/ML, (C-II) 1 ML Fill In 2.5 ML Carpuject&lt;/a&gt;</description><link>http://domopharma.blogspot.com/2012/05/hospira-recalls-hydromorphone-hci.html</link><author>noreply@blogger.com (Diordna)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-6400708663401817028.post-5580126856443540251</guid><pubDate>Fri, 09 Mar 2012 05:14:00 +0000</pubDate><atom:updated>2012-03-08T21:34:14.204-08:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">FDA</category><category domain="http://www.blogger.com/atom/ns#">Lucinactant</category><category domain="http://www.blogger.com/atom/ns#">Surfaxin</category><title>Surfaxin (Lucinactant) Approved By FDA For The Prevention Of Respiratory Distress Syndrome (RDS) In Premature Infants.</title><description>&lt;div style=&quot;font-family: Georgia, serif; font-size: 100%; font-style: normal; font-variant: normal; font-weight: normal; line-height: normal; &quot;&gt;FDA has approved Surfaxin (Lucinactant) for preventing premature infants from the respiratory distress syndrome (RDS).&lt;/div&gt;&lt;div&gt;&lt;div&gt;&lt;span &gt;The lungs of premature infants are not able to make enough surfactant, a liquid that coats the inside of the lungs and helps to keep them open. Without enough surfactant, the lungs collapse and the infant has difficulty breathing. Most babies who develop RDS show signs of breathing problems and a lack of oxygen at birth or within the first few hours after birth.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span &gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span &gt;Surfaxin is the fifth drug approved in the United States to treat RDS in premature infants. The other FDA-approved surfactants include Survanta (beractant), Curosurf (poractant alpha), Infasurf (calfactant), and Exosurf (colfosceril palmitate), which is no longer marketed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span &gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span &gt;A single randomized, active-controlled, multi-dose study involving 1,294 premature infants demonstrated the safety and efficacy of Surfaxin. Within 30 minutes of birth, infants in the study received either Surfaxin, Exosurf or Survanta. Surfaxin and Exosurf served as the primary comparison for this study; Survanta served as another comparison. Surfaxin demonstrated significant improvement in both RDS at 24 hours after birth and RDS-related mortality through two weeks, when compared with Exosurf.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span &gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span &gt;The most common side effects of Surfaxin are related to its administration down a premature infant’s breathing tube (endotracheal tube) and include endotracheal tube reflux, skin paleness, endotracheal tube obstruction, and need for dose interruption.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span &gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span &gt;Surfaxin is manufactured by Discovery Laboratories Inc. of Warrington, Pa.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;span &gt;&lt;a href=&quot;http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021746s000lbl.pdf&quot;&gt;Drug Label&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;div align=&quot;left&quot;&gt;&lt;table border=&quot;0&quot; w_idth=&quot;850&quot; cellspacing=&quot;4&quot; bordercolor=&quot;#99ccff&quot; cellpadding=&quot;3&quot; height=&quot;120&quot; style=&quot;font-family: Arial, sans-serif; font-size: 12px; &quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td bgcolor=&quot;#FFFFCC&quot; height=&quot;3&quot; class=&quot;details_table&quot;&gt;&lt;strong&gt;Drug Name(s)&lt;/strong&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; height=&quot;3&quot; class=&quot;details_table&quot;&gt;&lt;strong&gt;SURFAXIN (Brand Name Drug)&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor=&quot;#FFFFCC&quot; height=&quot;12&quot; class=&quot;details_table&quot;&gt;&lt;strong&gt;FDA Application No.&lt;/strong&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; height=&quot;12&quot; class=&quot;details_table&quot;&gt;&lt;strong&gt;(NDA) 021746&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor=&quot;#FFFFCC&quot; height=&quot;21&quot; class=&quot;details_table&quot;&gt;&lt;strong&gt;Active Ingredient(s)&lt;/strong&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; height=&quot;21&quot; class=&quot;details_table&quot;&gt;&lt;strong&gt;LUCINACTANT&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td bgcolor=&quot;#FFFFCC&quot; height=&quot;21&quot; class=&quot;details_table&quot;&gt;&lt;strong&gt;Company&lt;/strong&gt;&lt;/td&gt;&lt;td valign=&quot;top&quot; height=&quot;21&quot; class=&quot;details_table&quot;&gt;&lt;strong&gt;DISCOVERY LABORATORIES INC&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;FULL PRESCRIBING INFORMATION &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;1  INDICATIONS AND USAGE &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;SURFAXIN&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;®&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt; (lucinactant) Intratracheal Suspension is indicated for the prevention of respiratory &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;distress syndrome (RDS) in premature infants  at high risk for RDS.  SURFAXIN reduces the &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;incidence of RDS at 24 hours and mortality due to RDS. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;2  DOSAGE AND ADMINISTRATION &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;For intratracheal administration only. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;SURFAXIN should be administered  by or under the supervision of clinicians experienced in &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;intubation, ventilator management, and general care of premature infants. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;2.1  Dosing &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;The recommended dose of SURFAXIN is 5.8 mL  per kg birth weight.  Up to 4 doses of &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;SURFAXIN can be administered in the first 48 hours of life.  Doses should be given no more &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;frequently than every 6 hours. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;No information is available on doses greater than 5.8 mL per kg birth weight, the effects of more &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;than 4 doses, or dosing more frequently than every 6 hours. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Dosage may be determined from Table 1. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Table 1. Dosing Chart &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Birth Weight (g)  Total Dose (mL)  &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;600-649  &lt;span class=&quot;Apple-tab-span&quot; style=&quot;white-space:pre&quot;&gt;  &lt;/span&gt;3.5  &lt;span class=&quot;Apple-tab-span&quot; style=&quot;white-space:pre&quot;&gt;      &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;650-699  &lt;span class=&quot;Apple-tab-span&quot; style=&quot;white-space:pre&quot;&gt;  &lt;/span&gt;3.8  &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;700-749  &lt;span class=&quot;Apple-tab-span&quot; style=&quot;white-space:pre&quot;&gt;  &lt;/span&gt;4.1   &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;750-799  &lt;span class=&quot;Apple-tab-span&quot; style=&quot;white-space:pre&quot;&gt;  &lt;/span&gt;4.4   &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;800-849  &lt;span class=&quot;Apple-tab-span&quot; style=&quot;white-space:pre&quot;&gt;  &lt;/span&gt;4.6   &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;850-899  &lt;span class=&quot;Apple-tab-span&quot; style=&quot;white-space:pre&quot;&gt;  &lt;/span&gt;4.9   &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span &gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;900-949  &lt;span class=&quot;Apple-tab-span&quot; style=&quot;white-space:pre&quot;&gt;  &lt;/span&gt;5.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span style=&quot;font-family: Arial, sans-serif; font-size: 12px; &quot;&gt;950-999  &lt;/span&gt;&lt;span class=&quot;Apple-tab-span&quot; style=&quot;font-family: Arial, sans-serif; font-size: 12px; white-space: pre; &quot;&gt;  &lt;/span&gt;&lt;span style=&quot;font-family: Arial, sans-serif; font-size: 12px; &quot;&gt;5.5 &lt;/span&gt; &lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span style=&quot;font-family: Arial, sans-serif; font-size: 12px; &quot;&gt;1000-1049 &lt;span class=&quot;Apple-tab-span&quot; style=&quot;white-space:pre&quot;&gt;  &lt;/span&gt;5.8 &lt;/span&gt; &lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span style=&quot;font-family: Arial, sans-serif; font-size: 12px; &quot;&gt;1050-1099  &lt;span class=&quot;Apple-tab-span&quot; style=&quot;white-space:pre&quot;&gt;  &lt;/span&gt;6.1&lt;/span&gt; &lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span style=&quot;font-family: Arial, sans-serif; font-size: 12px; &quot;&gt;1100-1149 &lt;span class=&quot;Apple-tab-span&quot; style=&quot;white-space:pre&quot;&gt;  &lt;/span&gt;6.4&lt;/span&gt; &lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span style=&quot;font-family: Arial, sans-serif; font-size: 12px; &quot;&gt;1150-1199  &lt;span class=&quot;Apple-tab-span&quot; style=&quot;white-space:pre&quot;&gt;  &lt;/span&gt;6.7&lt;/span&gt; &lt;/div&gt;&lt;div align=&quot;left&quot;&gt;&lt;span style=&quot;font-family: Arial, sans-serif; font-size: 12px; &quot;&gt;1200-1250 &lt;span class=&quot;Apple-tab-span&quot; style=&quot;white-space:pre&quot;&gt;  &lt;/span&gt;7.0&lt;/span&gt; &lt;/div&gt;&lt;/div&gt;&lt;div align=&quot;left&quot; style=&quot;text-align: -webkit-right; font-family: Arial, sans-serif; &quot;&gt;&lt;b&gt;&lt;br /&gt;&lt;/b&gt;&lt;/div&gt;&lt;/div&gt;</description><link>http://domopharma.blogspot.com/2012/03/surfaxin-lucinactant-approved-by-fda.html</link><author>noreply@blogger.com (Diordna)</author><thr:total>1</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-6400708663401817028.post-7070838128687363801</guid><pubDate>Fri, 09 Mar 2012 04:52:00 +0000</pubDate><atom:updated>2012-03-08T21:11:42.080-08:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">AeroShot</category><category domain="http://www.blogger.com/atom/ns#">caffeine inhaler</category><category domain="http://www.blogger.com/atom/ns#">Drug Regulation</category><category domain="http://www.blogger.com/atom/ns#">FDA</category><title>AeroShot “caffeine inhaler” Warned By FDA For False Or Misleading Labeling And More.</title><description>&lt;a href=&quot;http://1.bp.blogspot.com/-pKWRMiy4po8/T1mQBsFTHTI/AAAAAAAAAIk/6uqBJJ-FnLA/s1600/AeroShot%2Bcaffeine%2Binhaler.jpg&quot; style=&quot;font-size: 100%; &quot;&gt;&lt;img style=&quot;display:block; margin:0px auto 10px; text-align:center;cursor:pointer; cursor:hand;width: 239px; height: 320px;&quot; src=&quot;http://1.bp.blogspot.com/-pKWRMiy4po8/T1mQBsFTHTI/AAAAAAAAAIk/6uqBJJ-FnLA/s400/AeroShot%2Bcaffeine%2Binhaler.jpg&quot; border=&quot;0&quot; alt=&quot;&quot; id=&quot;BLOGGER_PHOTO_ID_5717759560611208498&quot; /&gt;&lt;/a&gt;&lt;br /&gt;&lt;span style=&quot;font-size: 100%; &quot;&gt;&lt;b&gt;&lt;a href=&quot;http://domopharma.blogspot.com/2012/03/aeroshot-caffeine-inhaler-warned-by-fda.html&quot;&gt;AeroShot “caffeine inhaler”&lt;/a&gt;&lt;/b&gt;&lt;/span&gt;&lt;div&gt;&lt;span&gt;&lt;div style=&quot;font-size: 100%; &quot;&gt;FDA, the U.S. Food and Drug Administration, warned Breathable Foods Inc., makers of AeroShot, for false or misleading statements in the labeling of their product. FDA told the company that the Agency has questions about the safety of the “caffeine inhaler.” The agency was also concerned about children and adolescents using the product in combination with alcohol.&lt;/div&gt;&lt;div style=&quot;font-size: 100%; &quot;&gt;FDA works to protect consumers and acts very seriously about any problems caused by products it regulates.Consumers who believe they have suffered illness or injury from using AeroShot should also report those events to their regional &lt;a href=&quot;http://www.fda.gov/Safety/ReportaProblem/ConsumerComplaintCoordinators/default.htm&quot;&gt;FDA Consumer Complaint Coordinators&lt;/a&gt;. The agency also encourages healthcare providers to report to FDA any adverse events in their patients that are associated with &lt;b&gt;AeroShot&lt;/b&gt;. &lt;/div&gt;&lt;div style=&quot;font-size: 100%; &quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;div style=&quot;font-family: Arial, sans-serif; &quot;&gt;AeroShot Warning Letter:&lt;/div&gt;&lt;div style=&quot;font-family: Arial, sans-serif; &quot;&gt;&lt;span style=&quot;color: purple; text-decoration: none; &quot;&gt;&lt;a href=&quot;http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2012/ucm294774.htm&quot; style=&quot;color: purple; text-decoration: none; &quot;&gt;http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2012/ucm294774.htm&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-family: Arial, sans-serif; &quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;font-family: Arial, sans-serif; &quot;&gt; &lt;/div&gt;&lt;div style=&quot;font-family: Arial, sans-serif; &quot;&gt;How FDA regulates dietary supplements:&lt;/div&gt;&lt;div style=&quot;font-family: Arial, sans-serif; &quot;&gt;&lt;span style=&quot;color: purple; text-decoration: none; &quot;&gt;&lt;a href=&quot;http://www.fda.gov/Food/DietarySupplements/default.htm&quot; style=&quot;color: purple; text-decoration: none; &quot;&gt;http://www.fda.gov/Food/DietarySupplements/default.htm&lt;/a&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style=&quot;font-family: Arial, sans-serif; &quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;font-family: Arial, sans-serif; &quot;&gt; &lt;/div&gt;&lt;div style=&quot;font-family: Arial, sans-serif; &quot;&gt;Report a complaint to your regional Consumer Complaint Coordinator:&lt;/div&gt;&lt;div style=&quot;font-family: Arial, sans-serif; &quot;&gt;&lt;a href=&quot;http://www.fda.gov/Safety/ReportaProblem/ConsumerComplaintCoordinators/default.htm&quot; style=&quot;color: rgb(12, 17, 132); &quot;&gt;&lt;span&gt;http://www.fda.gov/Safety/ReportaProblem/ConsumerComplaintCoordinators/default.htm&lt;/span&gt;&lt;/a&gt;&lt;/div&gt;&lt;/div&gt;&lt;/span&gt;&lt;div style=&quot;font-size: 100%; &quot;&gt;&lt;span&gt;&lt;br /&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</description><link>http://domopharma.blogspot.com/2012/03/aeroshot-caffeine-inhaler-warned-by-fda.html</link><author>noreply@blogger.com (Diordna)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://1.bp.blogspot.com/-pKWRMiy4po8/T1mQBsFTHTI/AAAAAAAAAIk/6uqBJJ-FnLA/s72-c/AeroShot%2Bcaffeine%2Binhaler.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-6400708663401817028.post-1062542562345343787</guid><pubDate>Sat, 18 Feb 2012 12:33:00 +0000</pubDate><atom:updated>2012-02-18T04:49:03.053-08:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">MicroCHIPS</category><category domain="http://www.blogger.com/atom/ns#">OncoWikia</category><category domain="http://www.blogger.com/atom/ns#">Remote controlled drug delivery.</category><category domain="http://www.blogger.com/atom/ns#">teriparatide</category><title>MicroCHIPS,, Implanted Remote-Controlled Drug Delivery Could reduce Doctor Visits</title><description>OncoWikia Blog is reporting of a device that is implanted within patients body to deliver drugs, periodically by a physician, remotely. The device is made by MicroCHIPS, a USA company and the device delivered Teriparatide [recombinant human PTH(1–34)], an expensive hormone treatment that improves bone formation and reduces the risk of fracture in osteoporosis patients.&lt;br /&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;blockquote&gt;&quot;A microchip that continues to deliver  teriparatide with this or  similar consistency and efficiency over 12 to  24 months could improve  bone mass, density, architecture, and strength,&quot;  said study co-author  Robert Neer, Founder &amp;amp; Director of the  Massachusetts General  Hospital Bone Density Center and Associate  Professor of Medicine at  Harvard Medical School&lt;/blockquote&gt;&lt;/div&gt;Follow the link below for more information and the press release by MicroCHIPS.&lt;br /&gt;&lt;a href=&quot;http://oncowikia.blogspot.com/2012/02/microchips-implanted-remote-controlled.html&quot;&gt;MicroCHIPS,, Implanted Remote-Controlled Drug Delivery ~ Oncowikia Blog&lt;/a&gt;</description><link>http://domopharma.blogspot.com/2012/02/microchips-implanted-remote-controlled.html</link><author>noreply@blogger.com (ravenII)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-6400708663401817028.post-5693302714184037819</guid><pubDate>Thu, 16 Feb 2012 01:28:00 +0000</pubDate><atom:updated>2012-02-15T17:28:59.893-08:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">ADHD</category><category domain="http://www.blogger.com/atom/ns#">depressants</category><category domain="http://www.blogger.com/atom/ns#">drug abuse</category><category domain="http://www.blogger.com/atom/ns#">OTC</category><category domain="http://www.blogger.com/atom/ns#">painkillers</category><category domain="http://www.blogger.com/atom/ns#">Prescription for Danger</category><category domain="http://www.blogger.com/atom/ns#">Rx</category><title>Prescription for Danger, Prescription and Over-the-Counter Drug Abuse</title><description>&lt;div class=&quot;separator&quot; style=&quot;clear: both; text-align: center;&quot;&gt;&lt;a href=&quot;http://3.bp.blogspot.com/-mZ9ZWQXe7Ss/TzxbnaZQJ0I/AAAAAAAAAHs/4spb7aA5tfs/s1600/prescription+drug+abuse.jpg&quot; imageanchor=&quot;1&quot; style=&quot;margin-left: 1em; margin-right: 1em;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;505&quot; src=&quot;http://3.bp.blogspot.com/-mZ9ZWQXe7Ss/TzxbnaZQJ0I/AAAAAAAAAHs/4spb7aA5tfs/s640/prescription+drug+abuse.jpg&quot; width=&quot;640&quot; /&gt;&lt;/a&gt;&lt;/div&gt;Prescription and Over-the-Counter Drug Abuse Among the Nation’s Teens is trending and it is a cause that we should attend. The drugs abused by teens include high strength painkillers, ( those drugs prescribed after a surgery); depressants,( sleeping pills or anti-anxiety drugs); and stimulants,(drugs prescribed for attention deficit hyperactivity disorder (ADHD)). Among 12- and 13-year-olds, prescription drugs are the drug of choice and more than 2.1 million teens ages 12 to 17      reported abusing prescription drugs.&lt;br /&gt;They seem also abusing over-the-counter drugs, such as cough and cold remedies. All these are methods of getting high but an overdose of any of the above drugs could be dangerous and life threatening. &lt;br /&gt;There are many resources to gain knowledge about this danger, we located a document prepared by &quot;OFFICE OF NATIONAL DRUG CONTROL POLICY EXECUTIVE OFFICE OF THE PRESIDENT&quot; Called &quot; &lt;a href=&quot;http://www.theantidrug.com/pdfs/prescription_report.pdf&quot; target=&quot;_blank&quot;&gt;&lt;b&gt;Prescription for Danger (PDF)&lt;/b&gt;&lt;/a&gt; &quot;&lt;br /&gt;We think it is fine starter for everyone including parents to learn about the danger and take steps to prevent and protect our precious youth, following is an excerpt from the document, including the executive summery;&lt;br /&gt;&lt;br /&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;blockquote class=&quot;tr_bq&quot;&gt;National studies and published reports indicate that the abuse1 of prescription and over-the-counter (OTC) drugs to get high is a growing concern—particularly among teens—in the United States. In fact, more young people ages 12-17 abuse prescription drugs than any illicit drug except marijuana—more than cocaine, heroin, and methamphetamine combined. Prescription drugs provide benefits when used as directed under the care of a health provider. But when abused, they can be just as dangerous as illicit drugs.&lt;br /&gt;Though overall teen drug use is down significantly nationwide in recent years, there are troubling signs that teens view abusing prescription and OTC drugs as safer than using street drugs. Of even more concern is that many parents may not be addressing the dangers with their teens, though they can have an immediate impact on curbing the supply by cutting off the access to prescription drugs in their own home and by talking to their teen about the risks of drug use.&lt;/blockquote&gt;&lt;blockquote class=&quot;tr_bq&quot;&gt;&lt;div style=&quot;text-align: center;&quot;&gt;EXECUTIVE SUMMARY&lt;br /&gt;More teens abuse prescription drugs than any illicit drug except marijuana.&lt;br /&gt;• • •&lt;br /&gt;The majority of teens who abuse prescription drugs get them easily and for free, primarily from friends and relatives.&lt;br /&gt;• • •&lt;br /&gt;Teens are also abusing some over-the-counter (OTC) cough and cold remedies to get high, which is especially troubling given teens’ easy access to these products.&lt;br /&gt;• • •&lt;br /&gt;Many parents are not aware of teen prescription drug abuse. Teens say their parents are not discussing these dangers with them, even though research shows that parental disapproval is a powerful way to keep teens from using drugs.&lt;br /&gt;• • •&lt;br /&gt;Parents are in a unique position to immediately reduce teen access to prescription drugs because they are found in the home.&lt;br /&gt;• • •&lt;br /&gt;Teens are abusing prescription drugs because many believe the myth that these drugs provide a “safe” high and they are easily available.&lt;br /&gt;• • •&lt;br /&gt;There has been a dramatic increase in the number of poisonings and even deaths associated with the abuse of prescription and OTC drugs.&lt;br /&gt;• • •&lt;br /&gt;The prescription drugs most commonly abused by teens are painkillers, prescribed to treat pain; depressants, such as sleeping pills or anti-anxiety drugs; and stimulants, mainly prescribed to treat attention-deficit hyperactivity disorder (ADHD).&lt;br /&gt;• • •&lt;br /&gt;Some teens use prescription and OTC drugs with alcohol or other drugs, which could lead to dangerous drug interactions and other serious medical consequences. &lt;/div&gt;&lt;/blockquote&gt;&lt;/div&gt;</description><link>http://domopharma.blogspot.com/2012/02/prescription-for-danger-prescription.html</link><author>noreply@blogger.com (Diordna)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://3.bp.blogspot.com/-mZ9ZWQXe7Ss/TzxbnaZQJ0I/AAAAAAAAAHs/4spb7aA5tfs/s72-c/prescription+drug+abuse.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-6400708663401817028.post-4511792662221127678</guid><pubDate>Wed, 15 Feb 2012 01:03:00 +0000</pubDate><atom:updated>2012-02-16T05:22:34.232-08:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">domodrugs</category><category domain="http://www.blogger.com/atom/ns#">domopharma</category><category domain="http://www.blogger.com/atom/ns#">drug search</category><category domain="http://www.blogger.com/atom/ns#">MILLIPRED</category><category domain="http://www.blogger.com/atom/ns#">Pill millipedes</category><title>You Will not find Pill millipedes on DomoPharma! But you are certain to find Millipred</title><description>&lt;div&gt;&lt;table align=&quot;center&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; class=&quot;tr-caption-container&quot; style=&quot;margin-left: auto; margin-right: auto; text-align: center;&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;text-align: center;&quot;&gt;&lt;a href=&quot;http://2.bp.blogspot.com/-WcMK_1HEoC8/TzsDwv1DFMI/AAAAAAAAAHk/EAg0iK-BFug/s1600/pill+millipede.jpg&quot; imageanchor=&quot;1&quot; style=&quot;margin-left: auto; margin-right: auto;&quot;&gt;&lt;img border=&quot;0&quot; height=&quot;266&quot; src=&quot;http://2.bp.blogspot.com/-WcMK_1HEoC8/TzsDwv1DFMI/AAAAAAAAAHk/EAg0iK-BFug/s400/pill+millipede.jpg&quot; width=&quot;400&quot; /&gt;&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class=&quot;tr-caption&quot; style=&quot;text-align: center;&quot;&gt;Pill Millipede&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;b&gt;Pill millipedes&lt;/b&gt; are so called because they roll in to a ball when disturbed and this roll looks like a pill as you can see from the above photo, which is the works of &lt;a href=&quot;http://www.flickr.com/photos/limepics/&quot; style=&quot;background-color: transparent; color: #0063dc; text-decoration: none;&quot;&gt;george francis&lt;/a&gt;.  These millipedes are comparatively short and usually has about eleven to thirteen body segments. You might find &lt;a href=&quot;http://en.wikipedia.org/wiki/Pill_millipede&quot;&gt;Pill millipedes&lt;/a&gt; in wet woodlands, not in DomoPharma.&lt;br /&gt;&lt;br /&gt;But when you &lt;b&gt;search for the drug Millipred&lt;/b&gt;, on DomoPharma, you will be presented with more information with the support of DomoDrugs. Such as,&lt;br /&gt;What is Millipred;&lt;br /&gt;&lt;blockquote class=&quot;tr_bq&quot;&gt;&lt;div class=&quot;First &quot; style=&quot;text-align: justify;&quot;&gt;&quot;Millipred Oral Solution (10 mg Prednisolone per 5 mL)  is a dye free, pale to light yellow solution. Each 5 mL (teaspoonful) of  Millipred Oral Solution contains 13.4 mg prednisolone sodium phosphate  (10 mg prednisolone base) in a palatable, aqueous vehicle.&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;Inactive Ingredients: Millipred Oral Solution (10 mg Prednisolone per  5 mL) contains the following inactive ingredients: anti-bitter mask,  corn syrup, edetate disodium, glycerin, grape flavor,  hydroxyethylcellulose, methylparaben, potassium phosphate dibasic,  potassium phosphate monobasic, purified water, and sodium saccharin.&quot; &lt;/div&gt;&lt;/blockquote&gt;What is used for; (Basically it decreases your immune system&#39;s response to various diseases to  reduce symptoms such as pain, swelling and allergic-type reactions.)&lt;br /&gt;&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;blockquote class=&quot;tr_bq&quot;&gt;&lt;div class=&quot;First &quot;&gt;&quot;Millipred Oral Solution (10 mg Prednisolone per 5 mL) is indicated in the following conditions:&lt;/div&gt;&lt;h3&gt; 1. Allergic States&lt;/h3&gt;&lt;div class=&quot;First &quot;&gt;Control  of severe or incapacitating allergic conditions intractable to adequate  trials of conventional treatment in adult and pediatric populations  with: seasonal or perennial allergic rhinitis; asthma; contact  dermatitis; atopic dermatitis; serum sickness; drug hypersensitivity  reactions.&lt;/div&gt;&lt;h3&gt; 2. Dermatologic Diseases&lt;/h3&gt;&lt;div class=&quot;First &quot;&gt;Pemphigus;  bullous dermatitis herpetiformis; severe erythema multiforme  (Stevens-Johnson syndrome); exfoliative erythroderma; mycosis fungoides.&lt;/div&gt;&lt;h3&gt; 3. Edematous States&lt;/h3&gt;&lt;div class=&quot;First &quot;&gt;To  induce diuresis or remission of proteinuria in nephrotic syndrome in  adults with lupus erythematosus and in adults and pediatric populations,  with idiopathic nephrotic syndrome, without uremia.&lt;/div&gt;&lt;h3&gt; 4. Endocrine Disorders&lt;/h3&gt;&lt;div class=&quot;First &quot;&gt;Primary  or secondary adrenocortical insufficiency (hydrocortisone or cortisone  is the first choice; synthetic analogs may be used in conjunction with  mineralocorticoids where applicable; in infancy mineralocorticoid  supplementation is of particular importance); congenital adrenal  hyperplasia; hypercalcemia associated with cancer; nonsuppurative  thyroiditis.&lt;/div&gt;&lt;h3&gt; 5. Gastrointestinal Diseases&lt;/h3&gt;&lt;div class=&quot;First &quot;&gt;To tide the patient over a critical period of the disease in: ulcerative colitis; regional enteritis.&lt;/div&gt;&lt;h3&gt; 6. Hematologic Disorders&lt;/h3&gt;&lt;div class=&quot;First &quot;&gt;Idiopathic  thrombocytopenic purpura in adults; selected cases of secondary  thrombocytopenia; acquired (autoimmune) hemolytic anemia; pure red cell  aplasia; Diamond-Blackfan anemia.&lt;/div&gt;&lt;h3&gt; 7. Neoplastic Diseases&lt;/h3&gt;&lt;div class=&quot;First &quot;&gt;For the treatment of acute leukemia and aggressive lymphomas in adults and children.&lt;/div&gt;&lt;h3&gt; 8. Nervous System&lt;/h3&gt;&lt;div class=&quot;First &quot;&gt;Acute exacerbations of multiple sclerosis.&lt;/div&gt;&lt;h3&gt; 9. Ophthalmic Diseases&lt;/h3&gt;&lt;div class=&quot;First &quot;&gt;Uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids; temporal arteritis; sympathetic ophthalmia.&lt;/div&gt;&lt;h3&gt; 10. Respiratory Diseases&lt;/h3&gt;&lt;div class=&quot;First &quot;&gt;Symptomatic  sarcoidosis; idiopathic eosinophilic pneumonias; fulminating or  disseminated pulmonary tuberculosis when used concurrently with  appropriate antituberculous chemotherapy; asthma (as distinct from  allergic asthma listed above under “Allergic States”), hypersensitivity  pneumonitis, idiopathic pulmonary fibrosis, acute exacerbations of  chronic obstructive pulmonary disease (COPD), and Pneumocystis carinii  pneumonia (PCP) associated with hypoxemia occurring in an HIV (+)  individual who is also under treatment with appropriate anti-PCP  antibiotics. Studies support the efficacy of systemic corticosteroids  for the treatment of these conditions: allergic bronchopulmonary  aspergillosis, idiopathic bronchiolitis obliterans with organizing  pneumonia.&lt;/div&gt;&lt;h3&gt; 11. Rheumatic Disorders&lt;/h3&gt;&lt;div class=&quot;First &quot;&gt;As  adjunctive therapy for short term administration (to tide the patient  over an acute episode or exacerbation) in: psoriatic arthritis;  rheumatoid arthritis, including juvenile rheumatoid arthritis (selected  cases may require low dose maintenance therapy); ankylosing spondylitis;  acute and subacute bursitis; acute nonspecific tenosynovitis; acute  gouty arthritis; epicondylitis. For the treatment of systemic lupus  erythematosus, dermatomyositis (polymyositis), polymyalgia rheumatica,  Sjogren’s syndrome, relapsing polychondritis, and certain cases of  vasculitis.&lt;/div&gt;&lt;h3&gt; 12. Miscellaneous&lt;/h3&gt;Tuberculous  meningitis with subarachnoid block or impending block, tuberculosis  with enlarged mediastinal lymph nodes causing respiratory difficulty,  and tuberculosis with pleural or pericardial effusion (appropriate  antituberculous chemotherapy must be used concurrently when treating any  tuberculosis complications); trichinosis with neurologic or myocardial  involvement; acute or chronic solid organ rejection (with or without  other agents).&quot; &lt;/blockquote&gt;&lt;/div&gt;Including how the label looks like;&lt;br /&gt;&lt;blockquote class=&quot;tr_bq&quot;&gt;&amp;nbsp;PRINCIPAL DISPLAY PANEL — 237 mL Bottle Label&lt;br /&gt;&lt;div class=&quot;First &quot;&gt;&lt;b&gt;NDC 16477-510-08&lt;/b&gt; &lt;/div&gt;&lt;b&gt;Millipred™&lt;/b&gt; &lt;br /&gt;(Prednisolone Sodium Phosphate&lt;br /&gt;Oral Solution)&lt;br /&gt;&lt;span class=&quot;Bold Italics &quot;&gt;Equivalent to prednisolone&lt;/span&gt;&lt;br /&gt;&lt;b&gt;10 mg/5 mL&lt;/b&gt; &lt;br /&gt;&lt;b&gt;ALCOHOL FREE / DYE FREE&lt;/b&gt; &lt;br /&gt;&lt;b&gt;Rx Only&lt;/b&gt; &lt;br /&gt;&lt;b&gt;8 fl oz (237 mL)&lt;/b&gt; &lt;br /&gt;&lt;b&gt;LASER&lt;/b&gt; &lt;br /&gt;&lt;div class=&quot;post_image&quot; style=&quot;width: 300px;&quot;&gt;&lt;div class=&quot;post_image_img&quot;&gt;&lt;a href=&quot;http://druginserts.com/lib/images-rx/millipred/millipred-02.jpg&quot;&gt;&lt;img alt=&quot;PRINCIPAL DISPLAY PANEL -- 237 mL Bottle Label&quot; src=&quot;http://druginserts.com/lib/images-rx/millipred/millipred-02-300x138.jpg&quot; /&gt;&lt;/a&gt; &lt;/div&gt;&lt;div class=&quot;post_image_attr&quot;&gt;&lt;a href=&quot;http://druginserts.com/lib/images-rx/millipred/millipred-02.jpg&quot;&gt;(click image for full-size original)&lt;/a&gt; &lt;/div&gt;&lt;/div&gt;&lt;table cellpadding=&quot;3&quot; cellspacing=&quot;0&quot; class=&quot;contentTablePetite&quot;&gt; &lt;tbody&gt;&lt;tr&gt; &lt;td class=&quot;contentTableTitle&quot;&gt;&lt;b&gt;MILLIPRED&lt;/b&gt; &lt;br /&gt;&lt;span class=&quot;contentTableReg&quot;&gt;prednisolone sodium phosphate solution&lt;/span&gt; &lt;/td&gt; &lt;/tr&gt;&lt;tr&gt; &lt;td&gt;&lt;table cellpadding=&quot;5&quot; cellspacing=&quot;0&quot; class=&quot;formTablePetite&quot;&gt; &lt;tbody&gt;&lt;tr&gt; &lt;td class=&quot;formHeadingTitle&quot; colspan=&quot;4&quot;&gt;Product Information&lt;/td&gt; &lt;/tr&gt;&lt;tr class=&quot;formTableRowAlt&quot;&gt; &lt;td class=&quot;formLabel&quot;&gt;Product Type&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;HUMAN PRESCRIPTION DRUG&lt;/td&gt; &lt;td class=&quot;formLabel&quot;&gt;Item Code (Source)&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;NDC:16477-510&lt;/td&gt; &lt;/tr&gt;&lt;tr class=&quot;formTableRow&quot;&gt; &lt;td class=&quot;formLabel&quot; width=&quot;30%&quot;&gt;Route of Administration&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;ORAL&lt;/td&gt; &lt;td class=&quot;formLabel&quot; width=&quot;30%&quot;&gt;DEA Schedule&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr&gt; &lt;td&gt;&lt;table cellpadding=&quot;3&quot; cellspacing=&quot;0&quot; class=&quot;formTablePetite&quot;&gt; &lt;tbody&gt;&lt;tr&gt; &lt;td class=&quot;formHeadingTitle&quot; colspan=&quot;3&quot;&gt;Active Ingredient/Active Moiety&lt;/td&gt; &lt;/tr&gt;&lt;tr&gt; &lt;td class=&quot;formTitle&quot;&gt;Ingredient Name&lt;/td&gt; &lt;td class=&quot;formTitle&quot;&gt;Basis of Strength&lt;/td&gt; &lt;td class=&quot;formTitle&quot;&gt;Strength&lt;/td&gt; &lt;/tr&gt;&lt;tr class=&quot;formTableRowAlt&quot;&gt; &lt;td class=&quot;formItem&quot;&gt;&lt;b&gt;PREDNISOLONE SODIUM PHOSPHATE&lt;/b&gt; (PREDNISOLONE) &lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;PREDNISOLONE SODIUM PHOSPHATE&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;10 mg  in 5 mL&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr&gt; &lt;td&gt;&lt;table cellpadding=&quot;3&quot; cellspacing=&quot;0&quot; class=&quot;formTablePetite&quot;&gt; &lt;tbody&gt;&lt;tr&gt; &lt;td class=&quot;formHeadingTitle&quot; colspan=&quot;4&quot;&gt;Product Characteristics&lt;/td&gt; &lt;/tr&gt;&lt;tr class=&quot;formTableRowAlt&quot;&gt; &lt;td class=&quot;formLabel&quot;&gt;Color&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;YELLOW (Pale) &lt;/td&gt; &lt;td class=&quot;formLabel&quot;&gt;Score&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr class=&quot;formTableRow&quot;&gt; &lt;td class=&quot;formLabel&quot;&gt;Shape&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;&lt;br /&gt;&lt;/td&gt; &lt;td class=&quot;formLabel&quot;&gt;Size&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;&lt;br /&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr class=&quot;formTableRowAlt&quot;&gt; &lt;td class=&quot;formLabel&quot;&gt;Flavor&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;GRAPE&lt;/td&gt; &lt;td class=&quot;formLabel&quot;&gt;Imprint Code&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;&lt;br /&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr class=&quot;formTableRow&quot;&gt; &lt;td class=&quot;formLabel&quot;&gt;Contains&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr&gt; &lt;td&gt;&lt;table cellpadding=&quot;3&quot; cellspacing=&quot;0&quot; class=&quot;formTablePetite&quot;&gt; &lt;tbody&gt;&lt;tr&gt; &lt;td class=&quot;formHeadingTitle&quot; colspan=&quot;5&quot;&gt;Packaging&lt;/td&gt; &lt;/tr&gt;&lt;tr&gt; &lt;td class=&quot;formTitle&quot; width=&quot;1&quot;&gt;#&lt;/td&gt; &lt;td class=&quot;formTitle&quot;&gt;Item Code&lt;/td&gt; &lt;td class=&quot;formTitle&quot;&gt;Package Description&lt;/td&gt; &lt;td class=&quot;formTitle&quot;&gt;Multilevel Packaging&lt;/td&gt; &lt;/tr&gt;&lt;tr class=&quot;formTableRowAlt&quot;&gt; &lt;td class=&quot;formItem&quot;&gt;&lt;b&gt;1&lt;/b&gt; &lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;NDC:16477-510-08&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;237 mL in 1 BOTTLE&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;None&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr&gt; &lt;td&gt;&lt;br /&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr&gt; &lt;td class=&quot;normalizer&quot;&gt;&lt;table cellpadding=&quot;3&quot; cellspacing=&quot;0&quot; class=&quot;formTableMorePetite&quot;&gt; &lt;tbody&gt;&lt;tr&gt; &lt;td class=&quot;formHeadingReg&quot; colspan=&quot;4&quot;&gt;&lt;span class=&quot;formHeadingTitle&quot;&gt;Marketing Information&lt;/span&gt; &lt;/td&gt; &lt;/tr&gt;&lt;tr&gt; &lt;td class=&quot;formTitle&quot;&gt;Marketing Category&lt;/td&gt; &lt;td class=&quot;formTitle&quot;&gt;Application Number or Monograph Citation&lt;/td&gt; &lt;td class=&quot;formTitle&quot;&gt;Marketing Start Date&lt;/td&gt; &lt;td class=&quot;formTitle&quot;&gt;Marketing End Date&lt;/td&gt; &lt;/tr&gt;&lt;tr class=&quot;formTableRowAlt&quot;&gt; &lt;td class=&quot;formItem&quot;&gt;ANDA&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;ANDA078465&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;07/01/2009&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;&lt;br /&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;table cellpadding=&quot;3&quot; cellspacing=&quot;0&quot; class=&quot;formTableMorePetite&quot;&gt; &lt;tbody&gt;&lt;tr&gt; &lt;td class=&quot;formHeadingReg&quot; colspan=&quot;4&quot;&gt;&lt;span class=&quot;formHeadingTitle&quot;&gt;Labeler — &lt;/span&gt;Laser Pharmaceuticals, LLC        (614417132)     &lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;3&quot; cellspacing=&quot;0&quot; class=&quot;formTableMorePetite&quot;&gt; &lt;tbody&gt;&lt;tr&gt; &lt;td class=&quot;formHeadingReg&quot; colspan=&quot;4&quot;&gt;&lt;span class=&quot;formHeadingTitle&quot;&gt;Registrant — &lt;/span&gt;Pharmaceutical Associates, Inc. (044940096)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding=&quot;3&quot; cellspacing=&quot;0&quot; class=&quot;formTableMorePetite&quot;&gt; &lt;tbody&gt;&lt;tr&gt; &lt;td class=&quot;formHeadingReg&quot; colspan=&quot;4&quot;&gt;&lt;span class=&quot;formHeadingTitle&quot;&gt;Establishment&lt;/span&gt; &lt;/td&gt; &lt;/tr&gt;&lt;tr&gt; &lt;td class=&quot;formTitle&quot;&gt;Name&lt;/td&gt; &lt;td class=&quot;formTitle&quot;&gt;Address&lt;/td&gt; &lt;td class=&quot;formTitle&quot;&gt;ID/FEI&lt;/td&gt; &lt;td class=&quot;formTitle&quot;&gt;Operations&lt;/td&gt; &lt;/tr&gt;&lt;tr class=&quot;formTableRowAlt&quot;&gt; &lt;td class=&quot;formItem&quot;&gt;Pharmaceutical Associates, Inc.&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;&lt;br /&gt;&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;044940096&lt;/td&gt; &lt;td class=&quot;formItem&quot;&gt;MANUFACTURE&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;span class=&quot;EffectiveDate&quot;&gt;Revised: 09/2009&lt;/span&gt; &lt;span class=&quot;DistributorName&quot;&gt;Laser Pharmaceuticals, LLC&lt;/span&gt;&lt;/blockquote&gt;&lt;/div&gt;</description><link>http://domopharma.blogspot.com/2012/02/you-will-not-find-pill-millipedes-on.html</link><author>noreply@blogger.com (ravenII)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://2.bp.blogspot.com/-WcMK_1HEoC8/TzsDwv1DFMI/AAAAAAAAAHk/EAg0iK-BFug/s72-c/pill+millipede.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-6400708663401817028.post-6036490184478280345</guid><pubDate>Fri, 10 Feb 2012 01:06:00 +0000</pubDate><atom:updated>2012-02-09T17:31:24.440-08:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Bing for Pharma</category><category domain="http://www.blogger.com/atom/ns#">domodrugs</category><category domain="http://www.blogger.com/atom/ns#">domopharma</category><category domain="http://www.blogger.com/atom/ns#">Google for drugs</category><category domain="http://www.blogger.com/atom/ns#">Yahoo for Medicine</category><title>DomoPharma, Searching The Drug Universe</title><description>&lt;div style=&quot;text-align: center;&quot;&gt;&lt;a onblur=&quot;try {parent.deselectBloggerImageGracefully();} catch(e) {}&quot; href=&quot;http://4.bp.blogspot.com/-7tLu1PsedmY/TzRxxhyvVJI/AAAAAAAAG8Y/frOB79OQp6U/s1600/Trovafloxacin.png&quot;&gt;&lt;img style=&quot;display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 400px; height: 289px;&quot; src=&quot;http://4.bp.blogspot.com/-7tLu1PsedmY/TzRxxhyvVJI/AAAAAAAAG8Y/frOB79OQp6U/s400/Trovafloxacin.png&quot; alt=&quot;&quot; id=&quot;BLOGGER_PHOTO_ID_5707311723483976850&quot; border=&quot;0&quot; /&gt;&lt;/a&gt;&lt;span class=&quot;internal&quot;&gt;Trovafloxacin&lt;/span&gt;&lt;br /&gt;&lt;/div&gt;We would like to introduce the upcoming search engine for phama, DomoPharma. Even though it feels like to say &quot;Google for drugs&quot;, &quot;Bing for Pharma&quot;  or &quot;Yahoo for Medicine&quot;, we will not. Because DomoPharma is different from traditional search engines.&lt;br /&gt;We are very busy working on the innards of the site and hope to launch in the near future. We will keep you posted from this blog.&lt;br /&gt;&lt;br /&gt;For an example, when you search for &lt;a href=&quot;http://en.wikipedia.org/wiki/Kano_trovafloxacin_trial_litigation&quot; class=&quot;internal&quot; title=&quot;Trovafloxacin.png&quot;&gt;Trovafloxacin&lt;/a&gt;, you should and will find that it is an antibiotic manufactured by Pfizer and there is much more to this drug than it&#39;s chemical structure.</description><link>http://domopharma.blogspot.com/2012/02/domopharma-searching-drug-universe.html</link><author>noreply@blogger.com (ravenII)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://4.bp.blogspot.com/-7tLu1PsedmY/TzRxxhyvVJI/AAAAAAAAG8Y/frOB79OQp6U/s72-c/Trovafloxacin.png" height="72" width="72"/><thr:total>0</thr:total></item></channel></rss>